PATENT CLAIM ANALYSIS

Application Number: 15968466
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-04
Patent Classification: ["514", "292000"]

Abstract:
Therapeutic methods and compositions for treating fibrosis (e.g. scarring) are provided, as well as compositions comprising blebbistatin or a salt thereof and PLGA and nanoparticles comprising blebbistatin or a salt thereof and PLGA.

Claim (Index 22):
The method of  claim 21  wherein the nanoparticles are about 0.1 nm to 1000 um in diameter.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 93.0
- Lexical Diversity: 1.52
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13202324', '15254517', '15207718', '12947389', '14118448']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6884148905041291
- 35 USC 102 Novelty (BERT): 0.4989352245440822
- Combined Prediction Score: 0.6694669239081245
- Mean Citation Score: 151.54943400000005
- Max Citation Score: 178.7811
- Similarity Product: 113.07764851115942

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test